More than 200,000 are diagnosed annually with breast cancer and nearly 40,000 die. While most attention has been focused on the incidence of breast cancer in post-menopausal women, statistically, 23 percent of all breast cancers occur in women under 49 years of age. In fact, one in every 229 women between the ages of 30 and 39 will be diagnosed with breast cancer within the next 10 years.
The HALO Test is a simple, 5-minute, non-invasive breast screening and risk assessment exam recommended for women 25 years of age and older. The test can detect early cellular changes within the breast ducts, the area where more than 90% of breast cancer begins.